Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Value investing basics can set you on a path to success. Learn how to identify undervalued stocks and maximize returns.
20,091 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Palantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
A major fund recently added a sizable Mosaic position, highlighting growing interest in fertilizer stocks as potash p...
Fixed notes are more than a loan term. They can be a proactive hedge against vacancy gaps. Learn how investors using ...
Ethereum leads as the most undervalued major crypto per recent MVRV data, while XRP, ADA, and LINK also show notable ...
This analysis unpacks Interface (Tile)'s Q4 2025 earnings, translating numbers into a practical view for investors. L...
TJX posted stronger sales, yet its stock fell. This article breaks down the numbers, the market reaction, and practic...
Intuit reports stronger-than-expected fiscal second quarter as AI initiatives accelerate growth across its software l...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
Ethereum co-founder Vitalik Buterin floated a model where AI assists with wallet decisions but humans approve large t...
Redwire Corporation stock popped today as investors weighed contract news, analyst commentary, and growth potential. ...